Imaging beta-adrenoceptors in the human brain with (S)-1'- [18F]fluorocarazolol

Journal of Nuclear Medicine

Volumn 38, Issue 6, 1997, Pages 934-939

  Van Waarde, Aren ^a   Visser, Ton J ^b   Elsinga, Philip H ^b   De Jong, Bauke M ^b   Van Der Mark, Thom W ^b   Kraan, Jan ^b   Ensing, Kees ^b   Pruim, Jan ^b   Willemsen, Antoon T M ^b   Brodde, Otto Erich ^b   Visser, Gerben M ^b   Paans, Anne M J ^b   Vaalburg, Willem ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NONE

Author keywords

Beta adrenoceptors; Brain; Fluorine 18 fluorocarazolol; PET

Indexed keywords

BETA ADRENERGIC RECEPTOR; CARAZOLOL;

ADULT; ARTICLE; BINDING SITE; BLOOD BRAIN BARRIER; BRAIN MAPPING; DIAGNOSTIC IMAGING; HUMAN; HUMAN EXPERIMENT; KINETICS; LIGAND BINDING; NEUROTRANSMITTER RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; TISSUE DISTRIBUTION; VISUAL INFORMATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; BRAIN; CARBAZOLES; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; PINDOLOL; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030965847     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. De Pärmentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW. Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims. Brain Res 1990;525:71-77.
2. De Pärmentier F, Crompton MR, Katona CL, Horton RW. Beta-adrenoceptors in brain and pineal from depressed suicide victims. Pharmacol Toxicol 1992;711(suppl):86-95.
3. Joyce JN, Lexow N, Kim SJ, et al. Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics. Synapse 1992;10:228-246.
4. Valverius P, Borg S, Valverius MR, Hoffman PL, Tabakoff B. Beta-adrenergic receptor binding in brain of alcoholics. Exp Neurol 1989;105:280-286.
5. 2-receptors in prefrontal cortex and hippocampus. J Neurochem 1989;53:1772-1781.
6. Wëber C, Rigo M, Chinaglia G, Probst A, Palacios JM. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease. Synapse 1991;8:270-280.
7. Sutin J, Griffith R. Beta-adrenergic receptor blockade suppresses glial scar formation. Exp Neurol 1993;120:214-222.
8. Hodges-Savola C, Rogers SD, Ghilardi JR, Timm DR, Mantyh PW. Beta-adrenergic receptors regulate astrogliosis and cell proliferation in the central nervous system in vivo. Glia 1996;17:52-62.
9. Annane D. Médiation beta-adrenergique de la commande centrale de la ventilation: mythe ou realité? J Toxicol Clin Exp 1991;11:325-336.
10. Maloteaux JM. Drug and transmitter receptors in human brain. Characterization and localization of serotonin, dopamine and adrenergic receptors. Acta Neurol Belg 1986;86:61-129.
11. Flexner JB, Flexner LB, Church AC, Rainbow TC, Brunswick DJ. Blockade of beta-1 but not of beta-2 adrenergic receptors replicates propranolol's suppression of the cerebral spread of an engram in mice. Proc Natl Acad Sci USA 1985;82:7458-7461.
12. Stone EA, Platt JE. Brain adrenergic receptors and resistance to stress. Brain Res 1982;237:405-414.
13. De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW. Brain beta-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatment. Psychopharmacology 1991;105:283-288.
14. Garattini S, Samanin R. Drugs: guide and caveats to explanatory and descriptive approaches-I. A critical evaluation of the current status of antidepressant drugs. J Psychiatr Res 1984;18:373-390.
15. Okada F, Tokumitsu Y. Is the β-downregulation a prerequisite of the antidepressant activity? J Psychopharmacol 1994;8:62-63.
16. Jellingen KA. Pathology of Parkinson's disease: changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991;14:153-197.
17. 18F]flu-orocarazolol, ligands for the visualization of pulmonary β-adrenergic receptors with PET. Nucl Med Biol 1996;23:159-167.
18. 18F]fluorocarazolol in intact rats reflects radioligand binding to β-adrenoceptors. Eur J Pharmacol 1995;272:159-168.
19. 18F labeling of fluorocarazolol, a high-affinity β-adrenergic receptor antagonist. J Med Chem 1994;37:3219-3230.
20. Visser TJ, Van Waarde A, van der Mark TW, et al. Characterization of thoracic β-adrenoceptors in healthy volunteers using fluorocarazolol-PET [Abstract]. J Nucl Med 1996;37(suppl):71P.
21. Brown L, Deighton NM, Bals S, Spare receptors for beta-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J Cardiovasc Pharmacol 1992;19:222-232.
22. 50) of an enzymatic reaction. Biochem Pharmacol 1973;22:3099-3108.
23. 18F]-fluorocarazolol, in plasma of humans, rats and sheep. J Chromatogr B 1996;678:253-260.
24. Edwards E, Whitaker-Azmitia PM. Selective beta-antagonists are equally and highly potent at 5-HT sites in the rat hippocampus. Neuropharmacology 1987;26:93-96.
25. Nishio H, Nagakura Y, Segawa T. Interactions of carteolol and other beta-adrenoceptor blocking agents with serotonin receptor subtypes. Arch Int Pharmacodyn Ther 1989;302:96-106.
26. 125I)iodocyanopindolol? J Recept Res 1992;12: 369-387.
27. 1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers. Biochem Pharmacal 1988;37:3429-3433.
28. Van Waarde A, Meeder JG, Blanksma PK, et al. Suitability of CGP12177 and CGP26505 for quantitative imaging of β-adrenoceptors. Nucl Med Biol 1992;19:711-718.
29. Van Waarde A, Meeder JG, Blanksma PK, et al. Uptake of radioligands by rat heart and lung in vivo: CGP12177 does and CGP26505 does not reflect binding to β-adrenoceptors. Eur J Pharmacol 1992;222:107-112.
30. Van Waarde A, Elsinga PH, Anthonio RL, et al. Study of cardiac receptor ligands by positron emission tomography. In: Van der Wall EE, Blanksma PK, Niemeyer MG, et al, eds. Cardiac positron emission tomography: viability, perfusion, receptors and cardiomyopathy. Dordrecht, Germany: Kluwer Academic Publishers;1995:171-182.
31. 3H]CGP 12177. Eur J Pharmacol 1989;167:397-405.
32. Pazos A, Probst A, Palacios JM. Beta-adrenoceptor subtypes in the human brain: autoradiographic localization. Brain Res 1985;358:324-328.
33. Reznikoff GA, Manaker S, Rhodes CH, Winokur A, Rainbow TC. Localization and quantification of beta-adrenergic receptors in human brain. Neurology 1986;36:1067-1073.
34. 2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psych 1990;47:1038-1047.
35. 125]I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat and porcine hearts. Cardiovasc Res 1991;25:764-773.